Alane P Barnes insider trades
Open-market stock purchases and sales by Alane P Barnes, Chief Legal Officer at Biocryst Pharmaceuticals Inc, from SEC Form 4 filings since Jan 1, 2014.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +82%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 13, 2026 | BCRX Biocryst Pharmaceuticals Inc | Sold | $596K |
| May 13, 2026 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | — |
| Mar 16, 2026 | BCRX Biocryst Pharmaceuticals Inc | Sold | $1.4M |
| Mar 16, 2026 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | — |
| Dec 22, 2025 | BCRX Biocryst Pharmaceuticals Inc | Sold | $167K |
| Dec 19, 2025 | BCRX Biocryst Pharmaceuticals Inc | Sold (not open market) | $125K |
| Dec 17, 2025 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | — |
| Dec 17, 2025 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | — |
| Dec 15, 2025 | BCRX Biocryst Pharmaceuticals Inc | Sold | $162K |
| Dec 12, 2025 | BCRX Biocryst Pharmaceuticals Inc | Sold (not open market) | $64.6K |
| Dec 3, 2025 | BCRX Biocryst Pharmaceuticals Inc | Sold | $151K |
| Dec 2, 2025 | BCRX Biocryst Pharmaceuticals Inc | Sold | $367K |
| Dec 1, 2025 | BCRX Biocryst Pharmaceuticals Inc | Sold | $647K |
| Dec 1, 2025 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | — |
Companies traded
- BCRX Biocryst Pharmaceuticals Inc: 2 buys, 15 sales, last May 13, 2026